TP53 and triple-negative breast carcinoma: Consistent with these findings, a recent study tested for interaction between TP53 mutation status and integrative cluster analysis in 1420 breast tumors, indicating a close correlation between wildtype p53 and the presence of T cells in the tumor microenvironment of triple-negative breast cancer [39].